As part of its company expansion and increased activity in supporting clinical trials for small to medium size biotechs, PHARMExcel is delighted to have renewed its membership to the BioIndustry Association (BIA).
In support of the BIA, Yvanne Enever, CEO & Founder of PHARMExcel, and Russell Wheatcroft, COO at PHARMExcel will be attending the BioIndustry Association (BIA)’s Summer Networking Reception on Thursday, 13th July. This esteemed event will be held at the beautiful Langham Hotel in London.
PHARMExcel was delighted to be accepted as a member of the BIA in May 2022. The BIA serves as a prominent organisation that represents a diverse range of stakeholders within the life sciences sector. Membership to the BIA enables PHARMExcel to connect with stakeholders including small clinical stage biotechs, large pharmaceutical corporations, academics, and service providers catering to the life sciences industry. It is worth noting that a significant proportion of medicines currently undergoing pre-clinical and clinical development are associated with BIA’s esteemed members. As a leading voice in the UK life science industry, BIA plays a vital role in highlighting the challenges faced in innovation, research, and development.
Yvanne Enever, PHARMExcel’s CEO, expressed her enthusiasm for the BIA event, describing it as a unique and invaluable peer-to-peer networking opportunity. “This event provides an excellent forum for industry professionals like PHARMExcel to engage in discussions covering a wide range of topics, from scientific advancements to industry trends. With our focus in early phase clinical trials on gene therapies and vaccines, participation in this event enables the company to connect with world-class research and emerging biotech companies, fostering collaborations and facilitating further growth.”
Becoming a member of the BIA was a strategic decision for PHARMExcel, as it recognised the importance of this award-winning organisation in shaping the future of the UK life science industry. By joining forces with the BIA, PHARMExcel gains access to a vibrant network of like-minded professionals and key players in the life sciences sector, providing knowledge exchange and mutually beneficial partnerships.
PHARMExcel’s support at the BIA’s Summer Networking Reception signifies its commitment to expanding its horizons and forging meaningful connections within the bioscience community.
Yvanne Enever said “We’re dedicated to staying at the forefront of scientific advancements and collaborating with industry leaders to drive innovation in the field of biotechnology.”
PHARMExcel is an award-winning, full-service Contract Research Organisation (CRO) providing a flexible and innovative approach to clinical trial delivery. The company is recognised for its in-depth knowledge and experience of the clinical research environment, particularly in the UK, and has a network of regulatory and industry associates, allowing it to provide a global reach.
Media Contact
Katie Howe, Head of Marketing
E: katie.howe@pharmexcel-cro.com
T: +44 (0)20 3642 6654
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Its goal is to secure the UK’s position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people’s lives.
For further information, please go to www.bioindustry.org
